These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18066548

  • 21. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
    Di Paolo D, Pastorino F, Zuccari G, Caffa I, Loi M, Marimpietri D, Brignole C, Perri P, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M, Pagnan G.
    J Control Release; 2013 Sep 28; 170(3):445-51. PubMed ID: 23792118
    [Abstract] [Full Text] [Related]

  • 22. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
    Pagnan G, Di Paolo D, Carosio R, Pastorino F, Marimpietri D, Brignole C, Pezzolo A, Loi M, Galietta LJ, Piccardi F, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M.
    Clin Cancer Res; 2009 Feb 15; 15(4):1199-209. PubMed ID: 19228726
    [Abstract] [Full Text] [Related]

  • 23. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, Blaney SM, Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JS.
    Cancer Chemother Pharmacol; 2009 Jan 15; 63(2):229-38. PubMed ID: 18398615
    [Abstract] [Full Text] [Related]

  • 24. Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug.
    Alberts DS, Hallum AV, Stratton-Custis M, Garcia DJ, Gleason-Guzman M, Salmon SE, Santabarbara P, Niesor EJ, Floret S, Bentzen CL.
    Clin Cancer Res; 2001 May 15; 7(5):1246-50. PubMed ID: 11350890
    [Abstract] [Full Text] [Related]

  • 25. Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles.
    Okuda T, Kawakami S, Higuchi Y, Satoh T, Oka Y, Yokoyama M, Yamashita F, Hashida M.
    Int J Pharm; 2009 May 21; 373(1-2):100-6. PubMed ID: 19429294
    [Abstract] [Full Text] [Related]

  • 26. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
    Chen NE, Maldonado NV, Khankaldyyan V, Shimada H, Song MM, Maurer BJ, Reynolds CP.
    Mol Cancer Ther; 2016 Nov 21; 15(11):2653-2664. PubMed ID: 27530131
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM, Perkins J.
    J Vet Pharmacol Ther; 2008 Dec 21; 31(6):544-53. PubMed ID: 19000278
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR.
    Harris G, Ghazallah RA, Nascene D, Wuertz B, Ondrey FG.
    Otolaryngol Head Neck Surg; 2005 Nov 21; 133(5):695-701. PubMed ID: 16274795
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.
    Klein CE, Kastrissios H, Miller AA, Hollis D, Yu D, Rosner GL, Grinblatt DL, Larson RA, Ratain MJ.
    Cancer Chemother Pharmacol; 2006 Jan 21; 57(2):199-206. PubMed ID: 16158312
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
    Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Montaldo PG, Gambini C, Allen TM, Bogenmann E, Ponzoni M.
    Int J Cancer; 2003 May 01; 104(5):559-67. PubMed ID: 12594810
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.
    Główka FK, Karaźniewicz-Łada M, Grund G, Wróbel T, Wachowiak J.
    Bone Marrow Transplant; 2008 Oct 01; 42 Suppl 2():S67-70. PubMed ID: 18978748
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.